These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11400424)

  • 1. [Prevention secondary to ischemic cardiopathy at the lipid level in primary care in Aragon. PRECIAR study 1].
    Martínez Hernández AA; Aguilar Leñero MJ; Rabadán Mengíbar M; Hernansanz Iglesias F; González Ramos J; Marín Obáñez A
    Rev Esp Salud Publica; 2001; 75(2):143-9. PubMed ID: 11400424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of lipid lowering in patients with coronary artery disease by case method learning.
    Kiessling A; Zethraeus N; Henriksson P
    Int J Technol Assess Health Care; 2005; 21(2):180-6. PubMed ID: 15921057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease during hospitalization in 1996-97 and 1998-99].
    Pajak A; Kawecka-Jaszcz K; Jankowski P; Bilo G; Dubiel JS; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2003; 60(3):136-41. PubMed ID: 14575013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of long-term cardiac training on lipids concentration in patients with chronic heart ischemic disease treated with simvastatin].
    Kałka D; Sobieszczańska M; Kopka L; Marciniak W; Zawadzka-Bartczak E; Bak A; Popielewicz-Kautz A; Korzeniowska J; Janczak J; Adamus J
    Pol Merkur Lekarski; 2007 Feb; 22(128):101-6. PubMed ID: 17598652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trial of education, prompts, and opinion leaders to improve prescription of lipid modifying therapy by primary care physicians for patients with ischemic heart disease.
    Bloomfield HE; Nelson DB; van Ryn M; Neil BJ; Koets NJ; Basile JN; Samaha FF; Kaul R; Mehta JL; Bouland D
    Qual Saf Health Care; 2005 Aug; 14(4):258-63. PubMed ID: 16076789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Attitude change of Spanish cardiologist with respect to hypolipidemic treatment in secondary prevention. The role of outside hospital care].
    Plaza Pérez I; Taboada Taboada M; Bautista Herrero Jimeno J; Gómez Guindal JA; Román León MT
    Rev Esp Cardiol; 1998; 51 Suppl 6():54-62. PubMed ID: 10050145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study.
    Koren MJ; Hunninghake DB;
    J Am Coll Cardiol; 2004 Nov; 44(9):1772-9. PubMed ID: 15519006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization.
    Cooke CE; Hammerash WJ
    Clin Ther; 2006 Apr; 28(4):591-9. PubMed ID: 16750470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achievement of optimal combined lipid values in a managed care setting: is a new treatment paradigm needed?
    Sarawate CA; Cziraky MJ; Stanek EJ; Willey VJ; Corbelli JC; Charland SL
    Clin Ther; 2007 Jan; 29(1):196-209. PubMed ID: 17379061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and treatment of dyslipidemia in Canadian primary care: a retrospective cohort analysis.
    Petrella RJ; Merikle E; Jones J
    Clin Ther; 2007 Apr; 29(4):742-50. PubMed ID: 17617298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibrates in the secondary prevention of ischemic cardiopathy].
    Posadas Romero C
    Arch Cardiol Mex; 2001; 71 Suppl 1():S139-41. PubMed ID: 11565320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary heart disease and dyslipidemia: a cross-sectional evaluation of prevalence, current treatment, and clinical control in a large cohort of Spanish high-risk patients: the PRINCEPS study.
    de Rojas FD; De Frutos T; Ponte A; Chacón JM; Vitale GC;
    Prev Cardiol; 2009; 12(2):65-71. PubMed ID: 19476579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting.
    Mosca L; Merz NB; Blumenthal RS; Cziraky MJ; Fabunmi RP; Sarawate C; Watson KE; Willey VJ; Stanek EJ
    Circulation; 2005 Feb; 111(4):488-93. PubMed ID: 15687138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary management of dyslipidemia in high-risk patients: targets still not met.
    Yan AT; Yan RT; Tan M; Hackam DG; Leblanc KL; Kertland H; Tsang JL; Jaffer S; Kates ML; Leiter LA; Fitchett DH; Langer A; Goodman SG;
    Am J Med; 2006 Aug; 119(8):676-83. PubMed ID: 16887414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.